Total and LDL cholesterol variability over time may be a biomarker for higher dementia risk and cognitive decline.

COVID-19 “magnified” preexisting disparities for rural patients as compared with their urban counterparts, one study author ...

Ami Bhatt asks Kate Dalton to share details on the challenges of early feasibility studies from her perspective as a clinical site coordinator.

Ami Bhatt and Michael Mack explain the economics of AI use in the detection of subclinical cardiovascular disease.

The 2024 conference has 28 late-breakers plus plenty of basic and population science. More than anything, it’s a celebration.

The latest version of the LLM had high concordance with a multidisciplinary heart team in choosing between PCI and CABG.

In high- and standard-risk patients CAS and TCAR look good, but some worry about skill sets, learning curves, and ...

While statins can reduce LDL levels and ASCVD events, high Lp(a) poses an independent risk that will need attention, too.

There’s no “silver bullet” for this problem, which is largely driven by clinical inertia, but some efforts are chipping away ...

In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists, the medical community ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...